Patents by Inventor J. Glenn Morris, Jr.

J. Glenn Morris, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and device for sanitation using bacteriophages
    Patent number: 6699701
    Abstract: Methods and devices for sanitation using bacteriophage are disclosed. According to one embodiment of the present invention, a method for sanitation using at least one bacteriophage includes the steps of (1) storing the at least one bacteriophage in a container; and (2) applying the at least one bacteriophage to a surface to be sanitized with a dispersing mechanism. According to another embodiment of the present invention, a sanitation device that dispenses at least one bacteriophage includes a container, at least one bacteriophage stored in the container, and a dispersing mechanism that disperses the at least one bacteriophage from the container.
    Type: Grant
    Filed: January 11, 2001
    Date of Patent: March 2, 2004
    Assignee: Intralytix, Inc.
    Inventors: Alexander Sulakvelidze, J. Glenn Morris, Jr., Zemphira Alavidze, Gary R. Pasternack, Torrey C. Brown
  • Vibrio vulnificus molecular probes, antibodies, and proteins
    Patent number: 6183973
    Abstract: The present invention is directed to oligonucleotides used as amplification primers and assay probes for specific and sensitive for virulent strains of V. vulnificus. The target sequence of the probes and primers according to present invention is a capsular polysaccharide (CPS) transport gene (wza) of V. vulnificus. These probes can detect wza DNA or RNA in an unknown sample suspected to have pathogenic strains of V. vulnificus including human, animal, or environmental samples. The invention is also directed to in vitro-expressed protein from the cloned wza for production of polyclonal or monoclonal antibody that is specific for the wza gene product and will detect the V. vulnificus Wza protein in a sample comprising unknown protein.
    Type: Grant
    Filed: December 4, 1998
    Date of Patent: February 6, 2001
    Assignee: UMBI - University of Maryland Biotechnology Institute
    Inventors: Anita C. Wright, Jan L. Powell, J. Glenn Morris, Jr.
  • Preventing/treating neonatal NEC by administering lactobacillus salivarius and lactobacillus plantarum or a combination thereof
    Patent number: 6132710
    Abstract: Gastrointestinal tissue injury and infections are treated by orally administering Lactobacilli strains. The Lactobacilli strains prevent neonatal necrotizing enterocolitis tissue injury and necrotizing enterocolitis in preterm infants. Preterm infants, full-term infants, children and adults as well as animals may be given the Lactobacilli strains. The strains are Lactobacillus salivarius strain ATCC 202196 and Lactobacillus plantarum strain ATCC 202195. Further, the strains may be given individually or as a combination of the two strains. In addition, the strains are useful in treating diarrhea. The Lactobacilli strains normalize and balance bacterial milieu in the gastro-intestinal tract. The Lactobacilli strains may be in lyophilized capsule form. The capsule may be an enteric coated slow-release microcapsule. The Lactobacilli strains may also be administered by means of a naso-gastric tube, especially for preterm infants.
    Type: Grant
    Filed: March 17, 1997
    Date of Patent: October 17, 2000
    Assignee: ProBiotix, Inc.
    Inventors: Pinaki Panigrahi, Ira H. Gewolb, J. Glenn Morris, Jr.
  • Vibrio cholerae bengal serogroup-O139 capsular polysaccharide and protein conjugates thereof
    Patent number: 5653986
    Abstract: Substantially pure capsular polysaccharide obtained from Vibrio cholerae Bengal serogroup-O139, capsular polysaccharide-protein conjugates thereof, and antibodies having binding specificity to said capsular polysaccharide.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: August 5, 1997
    Assignee: University of Maryland at Baltimore
    Inventors: J. Glenn Morris, Jr., Judith A. Johnson, C. Allen Bush
  • Nucleic acid probes specific for pathogenic strains of vibrio vulnificus and method employing the same
    Patent number: 5258284
    Abstract: Nucleic acid probes specific for pathogenic stains of vibrio vulnificus and methods employing the same, comprising nucleic acid hybridization probes specific for the vvh gene of pathogenic strains of vibrio vulnificus.
    Type: Grant
    Filed: January 22, 1991
    Date of Patent: November 2, 1993
    Assignee: University of Maryland, School of Medicine
    Inventors: J. Glenn Morris, Jr., Anita Wright